Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: CARCINOMA, HEPATOCELLULAR - MORTALITY , . Treffer: 19

2018

Qu, Z; Ling, Q; Gwiasda, J; Xu, X; Schrem, H; Beneke, J; Kaltenborn, A; Krauth, C; Mix, H; Klempnauer, J; Emmanouilidis, N Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
Langenbecks Arch Surg. 2018; 403(5): 643-654. Doi: 10.1007/s00423-018-1696-8
Web of Science PubMed FullText FullText_MUG

 

2017

Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Douschan, P; Rainer, F; Stauber, R; Haybaeck, J; Denk, H; Lackner, C Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Liver Int. 2017; 37(4):600-610 Doi: 10.1111/liv.13325
Web of Science PubMed FullText FullText_MUG

 

Gwiasda, J; Schulte, A; Kaltenborn, A; Ramackers, W; Kleine, M; Beetz, O; Klempnauer, J; Emmanouilidis, N; Schrem, H Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinoma.
Surg Oncol. 2017; 26(2): 178-187. Doi: 10.1016/j.suronc.2017.03.004
Web of Science PubMed FullText FullText_MUG

 

2015

Hoffmann, K; Ganten, T; Gotthardtp, D; Radeleff, B; Settmacher, U; Kollmar, O; Nadalin, S; Karapanagiotou-Schenkel, I; von Kalle, C; Jäger, D; Büchler, MW; Schemmer, P Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
BMC Cancer. 2015; 15(11):392-392 Doi: 10.1186/s12885-015-1373-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Flecken, T; Schmidt, N; Hild, S; Gostick, E; Drognitz, O; Zeiser, R; Schemmer, P; Bruns, H; Eiermann, T; Price, DA; Blum, HE; Neumann-Haefelin, C; Thimme, R Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.
Hepatology. 2014; 59(4):1415-1426 Doi: 10.1002/hep.26731 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Friedrich, K; Wannhoff, A; Kattner, S; Brune, M; Hov, JR; Weiss, KH; Antoni, C; Dollinger, M; Neumann-Haefelin, C; Seufferlein, T; Schemmer, P; Schirmacher, P; Stremmel, W; Gotthardt, DN PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.
J Gastroenterol Hepatol. 2014; 29(7):1477-1484 Doi: 10.1111/jgh.12540
Web of Science PubMed FullText FullText_MUG

 

Hucke, F; Pinter, M; Graziadei, I; Bota, S; Vogel, W; Müller, C; Heinzl, H; Waneck, F; Trauner, M; Peck-Radosavljevic, M; Sieghart, W How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma.
J Hepatol. 2014; 61(6):1287-1296 Doi: 10.1016/j.jhep.2014.07.002
Web of Science PubMed FullText FullText_MUG

 

Hucke, F; Sieghart, W; Pinter, M; Graziadei, I; Vogel, W; Müller, C; Heinzl, H; Waneck, F; Trauner, M; Peck-Radosavljevic, M The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE.
J Hepatol. 2014; 60(1):118-126 Doi: 10.1016/j.jhep.2013.08.022
Web of Science PubMed FullText FullText_MUG

 

Stampfl, U; Bermejo, JL; Sommer, CM; Hoffmann, K; Weiss, KH; Schirmacher, P; Schemmer, P; Kauczor, HU; Richter, GM; Radeleff, BA; Longerich, T Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study.
J Vasc Interv Radiol. 2014; 25(7):1018-1026 Doi: 10.1016/j.jvir.2014.03.007
Web of Science PubMed FullText FullText_MUG

 

2013

Aigelsreiter, A; Ress, AL; Bettermann, K; Schauer, S; Koller, K; Eisner, F; Kiesslich, T; Stojakovic, T; Samonigg, H; Kornprat, P; Lackner, C; Haybaeck, J; Pichler, M Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
Br J Cancer. 2013; 108(9):1830-1837 Doi: 10.1038/bjc.2013.165 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Koschny, R; Brost, S; Hinz, U; Sykora, J; Batke, EM; Singer, S; Breuhahn, K; Stremmel, W; Walczak, H; Schemmer, P; Schirmacher, P; Ganten, TM Cytosolic and nuclear caspase-8 have opposite impact on survival after liver resection for hepatocellular carcinoma.
BMC Cancer. 2013; 13(5):532-532 Doi: 10.1186/1471-2407-13-532 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Peck-Radosavljevic, M; Stauber, RE; BCLC - now also an internationally acclaimed prognostic system?.
Liver Int. 2012; 32(7):1037-1038 Doi: 10.1111/j.1478-3231.2012.02840.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sotiropoulos, GC; Tagkalos, E; Fouzas, I; Vernadakis, S; Mathé, Z; Treckmann, J; Paul, A Liver transplantation for hepatocellular carcinoma using extended criteria donor grafts.
Transplant Proc. 2012; 44(9):2730-2733 Doi: 10.1016/j.transproceed.2012.09.021
Web of Science PubMed FullText FullText_MUG

 

2011

Hoffmann, K; Hinz, U; Hillebrand, N; Radeleff, BA; Ganten, TM; Schirmacher, P; Schmidt, J; Büchler, MW; Schemmer, P Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis.
Clin Transplant. 2011; 25(5):E541-E551 Doi: 10.1111/j.1399-0012.2011.01465.x
Web of Science PubMed FullText FullText_MUG

 

2008

Riedl, CC; Brader, P; Zanzonico, PB; Chun, YS; Woo, Y; Singh, P; Carlin, S; Wen, B; Ling, CC; Hricak, H; Fong, Y Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET.
Radiology. 2008; 248(2):561-570 Doi: 10.1148/radiol.2482071421 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Lubienski, A; Bitsch, RG; Schemmer, P; Grenacher, L; Düx, M; Kauffmann, GW Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Rofo. 2004; 176(12):1794-1802 Doi: 10.1055/s-2004-813669
Web of Science PubMed FullText FullText_MUG

 

Stadlbauer, V; Schaffellner, S; Kniepeiss, D; Jakoby, E; Stauber, R; Iberer, F; Tscheliessnigg, KH Experiences in liver transplantation for hepatocellular carcinoma.
Transplant Proc. 2004; 36(1):195-198 Doi: 10.1016/j.transproceed.2003.11.009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2001

Schrem, H; Schütze, S; Klempnauer, J [What's new in hepatobiliary surgery?].
Zentralbl Chir. 2001; 126(8):569-570 Doi: 10.1055/s-2001-16575
Web of Science PubMed FullText FullText_MUG

 

1993

Stauber, RE; Mischinger, HJ; Trauner, M; Pristautz, H Indications for liver transplantation in neoplasms of the liver.
Acta Med Austriaca. 1993; 20(3):57-60
Web of Science PubMed Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum